Laddar...
Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye
Intracameral injection of bevacizumab (Avastin) helped in the successful regression of an anterior chamber neovascular membrane in a painful blind eye. The effect was persistent even after six months of follow-up. This is the first report on intracameral administration of bevacizumab with six months...
Sparad:
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Medknow Publications
2007
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2635977/ https://ncbi.nlm.nih.gov/pubmed/17951906 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|